Skip to content

ASX Announcements 2021

Home » Investors » ASX Announcements » ASX Announcements 2021

2021

16.12.2021 - IDT Australia - Onshore mRNA Manufacturing ATM Outcome and Strategy Update

14.12.2021 - IDT Australia Limited Trading Halt Request

13.12.2021 - IDT Australia Limited Investor Update - mRNA

30.11.2021 - Successful Manufacture of Australia's 1st mRNA COVID-19 Vaccine Candidate

18.11.2021 - Form 3Y and 3Z - Mary Sontrop

16.11.2021 - IDT Australia 2021 AGM Voting Summary

16.11.2021 - IDT Australia 2021 AGM Presentation

21.10.2021 - Jobkeeper payments notice

15.10.2021 - IDT Australia Notice of AGM 2021

15.10.2021 - IDT-Australia-Limited-Director-Retirement.pdf

13.10.2021 - IDT Executes Manufacturing Agreement With Monash

08.10.2021 - Notice received from Regal Funds Management Asia Pte Limited

28.09.2021 - IDT Receives Sterile Licence From TGA

21.09.2021 - Date of Forthcoming AGM and Other Relevant Dates

15.09.2021 - Strategy Update

15.09.2021 - Supp Disclosure Regarding Sterile Readiness Agreement

25.08.2021 - IDT Australia Investor Highlights 2021

25.08.2021 -IDT Australia Annual Report 2021

25.08.2021 - IDT Australia Appendix 4G 30 June 2021

25.08.2021 - IDT Australia Appendix 4E 30 June 2021

23.08.2021 - Media Interest, MIPS’ COVID-19 Vaccine & Sterile Readiness

22.06.2021 - COVID-19 Vaccine Manufacturing discussions with Victorian Government and Monash Institute of Pharmaceutical Sciences

22.06.2021 - IDT Receives First Commercial Shipment of Medicinal Cannabis Flower through a Commercial Partnership with Clever Leaves

19.03.2021 – Covid-19 Vaccine – Feasibility Assessment

23.02.2021-IDT Australia Half Year Report 31 December 2020

23.02.2021-IDT Australia Appendix 4D December 2020

23.02.2021-IDT Australia FY21 Interim Results and Investor Update

23.02.2021-Appendix 2A